speaking intensity range; location of F0 within VRP pitch range, and slope of speaking curve.
Subglottic Air Escape Causing Subcutaneous Emphysema
Andrew J. Lerrick, MD (presenter) Objectives: Closure of a tracheocutaneous fistula risks air escape into the anterior neck. Vocal cord augmentation establishes a subglottic pressure gradient during exhalation. We present a patient who underwent these procedures concurrently in whom subcutaneous subsequently developed.
Methods:
A 66 year-old female developed a neck abscess following a dental procedure. She presented to the ER with a compromised airway, requiring intubation. She underwent two separate neck abscess drainage procedures by OMFS. Prolonged intubation necessitated a tracheotomy, performed by cardiothoracic surgery. She was subsequently weaned and decannulated.
Results: She was referred for dysphonia and a micro-tracheocutaneous fistula. Laryngoscopy revealed left vocal cord paralysis, not thought to be iatrogenic. Fistula closure with vocal cord augmentation was proposed. Fistula tract excision was followed by a two-layer muscle and skin closure. An air-tight seal was confirmed on high-pressure ventilation. Gelfoam was injected into the left vocal cord. She was discharged the morning after surgery. Twelve hours later she returned to the ER with rapid onset of cervicofacial subcutaneous emphysema. A pressure dressing was applied to the anterior neck. The subcutaneous emphysema subsided, being sub-totally resorbed within 24 hours.
Conclusions: Despite the delay in onset, once conditions developed a percentage of subglottic air preferentially escaped through the small defect in the anterior tracheal wall, rather than exclusively through the larger hemi-glottic aperture, causing subcutaneous emphysema. Caution should be exercised in performing these procedures simultaneously.
Supraglottic Laryngeal Abscess of Idiopathic Etiology Secondary to
Community-Acquired, Methicillinresistant Staphylococcus aureus Alexander P. Marston (presenter); Ian J. Lalich, MD; Amy C. Dearking, MD; Laura J. Orvidas, MD Objectives: Prior to the widespread use of antibiotics, laryngeal abscesses typically presented secondary to systemic illnesses. Today, laryngeal abscesses are rarely observed, and most result from disease processes intrinsic to the larynx, such as airway instrumentation or malignancy. This report describes the unique case of an arytenoid abscess of insidious etiology. A supraglottic laryngeal abscess of this anatomic location has not previously been described in the literature and is of particular interest given the increasing prevalence of community acquired, methicillin-resistant Staphylococcus aureus (MRSA). We seek to characterize the presentation, work-up, and treatment of this condition.
Methods: A single case of an arytenoid abscess is described. The electronic medical record was used to collect demographic and clinical information.
Results: The patient had no prior history of laryngeal disease or airway instrumentation; however, her past medical history was significant for poorly controlled type 1 diabetes mellitus, as well as alcohol and methamphetamine abuse. Severe dysphagia and hoarseness prompted computerized tomographic imaging of the neck, which revealed a laryngeal abscess. Incision and drainage under direct laryngoscopy identified an abscess involving the right arytenoid with extension into the interarytenoid space. Cultures at the time of surgery grew MRSA, and biopsy of the abscess cavity was negative for malignancy. Following surgical drainage and appropriate antibiotic therapy, the patient recovered without long-term sequelae.
Conclusions: Laryngeal abscesses are rarely encountered in modern practice. This case offers a previously undescribed example of an idiopathic arytenoid abscess in the setting of an increasingly common infection, community acquired, MRSA.
Tacrolimus Prevents the Development of Laryngotracheal Stenosis in the Novel rat Model
Koji Araki, MD, PhD (presenter); Daisuke Mizokami, MD; Nobuaki Tanaka, MD; Masayuki Tomifuji, MD; Taku Yamashita, MD, PhD; Akihiro Shiotani, MD, PhD Objectives: Acquired laryngotracheal stenosis (LTS) is a challenging problem for otolaryngologists. Modulating the wound healing of airway mucosa is the key component for treating LTS. Drug-eluting stents (DESs) with immunosuppressants as Tacrolimus have been dominant for the treatment of coronary artery diseases in the interventional cardiology owing to their efficacy in significantly reducing restenosis. Several studies suggested Tacrolimus might potentially have inhibitory effects on airway stenosis as seen in coronary DESs. The objective of the present study is to determine whether immunosuppressants modulate the wound healing of airway mucosa and prevent obstructive airway disease in an acute injury animal model.
Methods:
The authors recently reported the novel reliable LTS model in rats, whose laryngotracheal mucosa was scraped with LArYNGOLOGY
